Imaging Post-Stroke Recovery: Using MEG to Evaluate Cognition

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorJohns Hopkins University

About this trial

This is a study using magnetoencephalography (MEG) to look at recovery in those with minor stroke. The investigators know that these individuals report difficulties in attention, concentration, multi-tasking, energy level, and processing speed that appear to be independent of lesion size or location. The underlying pathophysiology is unclear; however, anecdotally, many individuals are significantly improved by 6 months post-stroke. One hypothesis is that a single lesion, regardless of size, may disrupt the classic neural networks required for cognitive function. The investigators are currently collecting data to better characterize these difficulties and stroke patients' recovery as part of a previously approved recovery study. In this sub-study, the investigators propose to add MEG at 1 and 6 months in a subset of individuals with small: 1) subcortical, and 2) cortical lesions. The investigators will partner with colleagues at the University of Maryland (College Park), who are well experienced with MEG to conduct this research. In addition a control population of age-similar individuals will be recruited for comparison. Cerebral activation patterns of individuals with stroke versus controls will be compared, both across patients with stroke at a given time point, and within subjects from 1 to 6 months to determine the association of abnormal activation with cognitive dysfunction and recovery.

\*\*The investigators have recently extended follow-up by adding an additional assessment at 12 months and will enroll additional participants (up to 40 patients with minor stroke, 15 age-similar controls).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults (≥18 years) admitted to Bayview Medical Center Neurology.

Evidence of acute ischemic stroke (CT or MRI)- lacunar stroke or branch occlusion (M3/A3/P3 or smaller) OR NIHSS ≤ 8 on admission.

Competent speaker of English (by self or family report) prior to stroke.

Return for follow-up 4-6 weeks post event (+/- 4 wks).

Disqualifiers

Primary intracerebral hemorrhage- as evidenced by blood on head CT or MRI.

Previous neurological disease (e.g., dementia, multiple sclerosis, prior symptomatic stroke). Incidental asymptomatic lacunar strokes found on imaging will not be excluded as prior disease.

Uncorrected hearing or visual loss.

Large vessel occlusion.

Trial population

Participants will be recruited from those recently hospitalized with minor stroke at Johns Hopkins Bayview Medical Center (see inclusion criteria). Controls will include friends, family, and other volunteers of similar age meeting Inclusion Criteria.

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

  • Magnetoencephalography (MEG)

    Diagnostic test

    Participants will undergo MEG at the University of Maryland (College Park) to measure cerebral activity while performing a visual naming task. The Montreal Cognitive Assessment (MOCA) will also be administered.

Treatment groups

55 Participants
are divided into 2 treatment groups
Group A: Minor Stroke1 intervention
Group B: Controls1 intervention

Trial outcomes

Primary outcomes

1

Cerebral Activity Measured Using Magnetoencephalography (MEG)

Global patterns of cerebral activity as well as individual brain areas important for cognitive processing will be analyzed for differences with respect to amplitude, latency, and frequency.

Time frame
Up to 10 weeks
2

Cerebral Activity Measured Using Magnetoencephalography (MEG)

Global patterns of cerebral activity as well as individual brain areas important for cognitive processing will be analyzed for differences with respect to amplitude, latency, and frequency.

Time frame
Up to 6 months
3

Cerebral Activity Measured Using Magnetoencephalography (MEG)

Global patterns of cerebral activity as well as individual brain areas important for cognitive processing will be analyzed for differences with respect to amplitude, latency, and frequency.

Time frame
Up to 12 months
4

Reaction Time

Reaction times will be recorded and compared during the visual naming task

Time frame
Up to 10 weeks

Secondary outcomes

1

MOCA

Scores on the MOCA will be compared between those with minor stroke and controls

Time frame
Up to 10 weeks
2

MOCA

Scores on the MOCA will be compared between those with minor stroke and controls

Time frame
Up to 6 months
3

MOCA

Scores on the MOCA will be compared between those with minor stroke and controls

Time frame
Up to 12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Johns Hopkins University

Lead sponsor

University of Maryland, College Park

Collaborator

American Heart Association

Collaborator